Comparison of fluid and flunixin meglumine therapy in combination and individually in the treatment of toxic mastitis.
During a three-year study, 54 cows with toxic mastitis were allocated randomly to one of three treatment groups (A, B and C). Each cow was re-examined within 24 hours of the initial examination, and, during this time, group A received fluid therapy (45 liters of intravenous isotonic electrolyte solution) and flunixin meglumine (2000 mg), group B received fluid therapy only, and group C received flunixin meglumine only. In addition all the cases were treated with parenteral and intramammary tetracyclines, oxytocin and calcium boroglucoanate. There was no significant difference in the rate of survival between the treatment groups and 29 of the cows (53.7 per cent, 95 per cent confidence interval of 39 to 67 per cent) survived.
Green
M J
MJ
Orchard Veterinary Group, Glastonbury, Somerset.
Green
L E
LE
Cripps
P J
PJ
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001888:Boric Acids / Q000008:administration & dosage; D002417:Cattle; D003002:Clonixin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D005440:Fluid Therapy / Q000379:methods*; D008414:Mastitis, Bovine / Q000628:therapy*; D010121:Oxytocin / Q000008:administration & dosage
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001888:Boric Acids; D010121:Oxytocin; C034286:borogluconate; C014558:flunixin meglumine; D003002:Clonixin